Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Inflammatory Bowel Diseases

  Free Subscription


2 Aliment Pharmacol Ther
3 Am J Gastroenterol
1 Ann Intern Med
1 Clin Exp Immunol
2 Clin Res Hepatol Gastroenterol
1 Gastroenterol Hepatol
2 Gastroenterology
8 Inflamm Bowel Dis
1 J Crohns Colitis
3 J Gastroenterol
1 PLoS One
1 Scand J Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. SAIFUDDIN A, Kent AJ, Mehta SJ, Hicks LC, et al
    Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
    Aliment Pharmacol Ther. 2022 Oct 5. doi: 10.1111/apt.17223.
    PubMed         Abstract available

  2. BURGESS CJ, Jackson R, Chalmers I, Russell RK, et al
    The inexorable increase of biological exposure in paediatric inflammatory bowel disease: a Scottish, population-based, longitudinal study.
    Aliment Pharmacol Ther. 2022 Oct 4. doi: 10.1111/apt.17217.
    PubMed         Abstract available

    Am J Gastroenterol

    Continuing Medical Education Questions: October 2022.
    Am J Gastroenterol. 2022;117:1564.
    PubMed         Abstract available

  4. SHMIDT E, Dubinsky MC
    Inflammatory Bowel Disease and Pregnancy.
    Am J Gastroenterol. 2022;117.

  5. GU P, Luo J, Kim J, Paul P, et al
    Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
    Am J Gastroenterol. 2022;117:1639-1647.
    PubMed         Abstract available

    Ann Intern Med

  6. OLIVER D, Talley NJ
    In active Crohn disease, risankizumab increased clinical remission and endoscopic response at 12 wk.
    Ann Intern Med. 2022 Oct 4. doi: 10.7326/J22-0080.
    PubMed         Abstract available

    Clin Exp Immunol

  7. HU M, Chen Z, Liao Y, Wu J, et al
    Clinical value of the expression levels of protein tyrosine phosphatase non-receptor type 22.6 mRNA in peripheral blood mononuclear cells in Crohn's disease.
    Clin Exp Immunol. 2022;209:311-315.
    PubMed         Abstract available

    Clin Res Hepatol Gastroenterol

  8. VEISMAN I, Lederer NB, Ukashi O, Kopylov U, et al
    Top 25 cited articles on Covid-19 and IBD: A bibliometric analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101959.
    PubMed         Abstract available

  9. GONZALEZ-MORCILLO G, Calderon-Hernanz B, Serrano-Lopez de Las Hazas J, de Hita-Santabaya AI, et al
    Ribavirin-resistant chronic norovirus infection-associated enteropathy in common variable immunodeficiency. Case report and review of the literature.
    Clin Res Hepatol Gastroenterol. 2022;46:101956.
    PubMed         Abstract available

    Gastroenterol Hepatol

  10. NUNEZ L, Mesonero F, Rodriguez de Santiago E, Die J, et al
    High incidence of surgery and initiation of medical therapies after colectomy for ulcerative colitis or inflammatory bowel disease unclassified.
    Gastroenterol Hepatol. 2022 Sep 14. pii: S0210-5705(22)00216.
    PubMed         Abstract available


  11. ARMSTRONG HK, Bording-Jorgensen M, Santer DM, Zhang Z, et al
    Unfermented beta-fructan fibers fuel inflammation in select inflammatory bowel disease patients.
    Gastroenterology. 2022 Sep 29. pii: S0016-5085(22)01150.
    PubMed         Abstract available

  12. D'AMICO F, Peyrin-Biroulet L, Danese S
    Is Selectivity the JAKpot Winner for Inflammatory Bowel Disease Treatment?
    Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01065.

    Inflamm Bowel Dis

  13. TSAI L, McCurdy JD, Ma C, Jairath V, et al
    Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.
    Inflamm Bowel Dis. 2022;28:1477-1484.
    PubMed         Abstract available

  14. ADLER J, Eder SJ, Gebremariam A, Moran CJ, et al
    Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn's Disease.
    Inflamm Bowel Dis. 2022;28:1537-1542.
    PubMed         Abstract available

  15. SANTIAGO M, Dias CC, Alves C, Ministro P, et al
    The Magnitude of Crohn's Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review.
    Inflamm Bowel Dis. 2022;28:1527-1536.
    PubMed         Abstract available

  16. LUPU G, Weaver KN, Herfarth HH, Barnes EL, et al
    Vancomycin Is Effective in the Treatment of Chronic Inflammatory Conditions of the Pouch.
    Inflamm Bowel Dis. 2022;28:1610-1613.

  17. ATTAUABI M, Dahlerup JF, Poulsen A, Hansen MR, et al
    Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based Study.
    Inflamm Bowel Dis. 2022;28:1618-1622.

  18. CHEN HM, MacDonald JA
    Molecular Network Analyses Implicate Death-Associated Protein Kinase 3 (DAPK3) as a Key Factor in Colitis-Associated Dysplasia Progression.
    Inflamm Bowel Dis. 2022;28:1485-1496.
    PubMed         Abstract available

  19. JORDI SBU, Begre S, Misselwitz B
    Should a Psychologist Be a Mandatory Component of IBD Consults? Yes-Authors' Reply.
    Inflamm Bowel Dis. 2022;28:e138-e139.

  20. LUTZ M, Hayney MS, Farraye FA, Caldera F, et al
    A Note on Monkeypox for Our Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Oct 6. pii: 6749562. doi: 10.1093.

    J Crohns Colitis

  21. HANZEL J, Bossuyt P, Pittet V, Samaan M, et al
    Development of a Core Outcome Set for Real-World Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation (ECCO) Position Paper.
    J Crohns Colitis. 2022 Oct 3. pii: 6747109. doi: 10.1093.
    PubMed         Abstract available

    J Gastroenterol

  22. OHARA J, Nemoto T, Maeda Y, Ogata N, et al
    Deep learning-based automated quantification of goblet cell mucus using histological images as a predictor of clinical relapse of ulcerative colitis with endoscopic remission.
    J Gastroenterol. 2022 Oct 3. pii: 10.1007/s00535-022-01924.
    PubMed         Abstract available

  23. NOGUCHI T, Ishihara S, Uchino M, Ikeuchi H, et al
    Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn's disease.
    J Gastroenterol. 2022 Oct 2. pii: 10.1007/s00535-022-01927.
    PubMed         Abstract available

  24. WANG Z, Iida N, Seishima J, Okafuji H, et al
    Patient-derived Enterococcus faecium with inflammatory genotypes promote colitis.
    J Gastroenterol. 2022;57:770-783.
    PubMed         Abstract available

    PLoS One

  25. ELAMIR A, Shaker O, Kamal M, Khalefa A, et al
    Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease.
    PLoS One. 2022;17:e0275267.
    PubMed         Abstract available

    Scand J Gastroenterol

  26. NISHIO M, Hirasawa K, Chiba S, Ozeki Y, et al
    Endoscopic resection is feasible for high-grade dysplasia in patients with ulcerative colitis.
    Scand J Gastroenterol. 2022 Oct 6:1-6. doi: 10.1080/00365521.2022.2107878.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.